What is Bio-Rad Laboratories's SG&A?

Bio-Rad Laboratories (BIO) reported SG&A of $212.4M in Q1 2026.

How has Bio-Rad Laboratories's SG&A changed year-over-year?

Bio-Rad Laboratories's SG&A increased by 1.7% year-over-year, from $208.8M to $212.4M.

What is the long-term trend for Bio-Rad Laboratories's SG&A?

Over 4 years (2021 to 2025), Bio-Rad Laboratories's SG&A has grown at a -0.9% compound annual growth rate (CAGR), from $877.12M to $844.3M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Bio-Rad Laboratories BIO SG&A

SG&A at other companies

AbbottABT

$3.74B+22.2%

Becton, Dickinson and CompanyBDX

$1.21B+8.6%

Thermo Fisher ScientificTMO

$2.18B+5.0%

DanaherDHR

$1.86B+0.1%

RevvityRVTY

$253.88M+1.7%

Agilent TechnologiesA

$465M+2.4%

Other financials

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation

See full

Market cap$7.56B+10.3%

Enterprise value$8.04B+4.2%

P/E44.8×—

P/S2.9×+0.2×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Rad Laboratories's SG&A?: Bio-Rad Laboratories (BIO) reported SG&A of $212.4M in Q1 2026.
How has Bio-Rad Laboratories's SG&A changed year-over-year?: Bio-Rad Laboratories's SG&A increased by 1.7% year-over-year, from $208.8M to $212.4M.
What is the long-term trend for Bio-Rad Laboratories's SG&A?: Over 4 years (2021 to 2025), Bio-Rad Laboratories's SG&A has grown at a -0.9% compound annual growth rate (CAGR), from $877.12M to $844.3M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.